Application of Emerging Technologies for Cancer Research (R21)

The summary for the Application of Emerging Technologies for Cancer Research (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Application of Emerging Technologies for Cancer Research (R21): -Purpose. This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications proposing exploratory research projects to evaluate the performance of emerging molecular analysis technologies and develop applications for an appropriate cancer-relevant biological system. These systems may cover cancer-relevant molecular analyses in vitro, in situ, and/or in vivo. The thrust of effort in the projects proposed in response to this FOA must be on emerging technology application rather than on technology development. Emerging technology is one that has passed the initial developmental stage and shows promise but has not been evaluated/developed in the context of the proposed application and has not been commercialized. Responsive technologies encompass relevant methods, techniques, tools, instrumentation, and devices (but not software or informatics solutions). This FOA is part of the broader NCI-sponsored program Innovative Molecular Analysis Technologies (IMAT). Several IMAT FOAs of identical or closely related scientific scope using various funding mechanisms are available. To facilitate selection, a separate Notice in the NIH Guide for Grants and Contracts provides a brief cross-comparison and links to all the IMAT FOAs. See NOT-CA-08-003. -Mechanism of Support. This FOA will utilize the NIH R21 award mechanism for exploratory (pilot) research projects. This FOA runs in parallel with another FOA of identical scientific scope, RFA-CA-08-008 that uses the NIH R33 award mechanism and is designed to fund Developmental Phase II projects. -Funds Available and Anticipated Number of Awards The NCI intends to commit a total of approximately $1,500,000 to this FOA in fiscal year 2009 to award approximately 10 to 15 grants.